- Investing Ideas
- /
- Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies
Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
8
Companies with a Value score of at least 3, ordered by Value score
8 companies
Merck
Market Cap: US$199.2b
Operates as a healthcare company worldwide.
MRK
US$81.20
7D
-13.8%
1Y
-31.3%
Regeneron Pharmaceuticals
Market Cap: US$59.3b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN
US$680.10
7D
0%
1Y
n/a
Pfizer
Market Cap: US$124.3b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$21.77
7D
-12.3%
1Y
-17.6%
Bristol-Myers Squibb
Market Cap: US$103.2b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$54.70
7D
0%
1Y
6.1%
Gilead Sciences
Market Cap: US$129.1b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$110.25
7D
0%
1Y
45.4%
Thermo Fisher Scientific
Market Cap: US$165.4b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
US$607.50
7D
0%
1Y
3.8%
AbbVie
Market Cap: US$309.7b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$189.41
7D
0%
1Y
n/a
Amgen
Market Cap: US$153.8b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$264.80
7D
0%
1Y
n/a